May 27, 2016
Chelsea Therapeutics International Inc. has agreed to pay $5.5 million in cash to settle an investor's putative securities class action stemming from alleged misstatements about its blood pressure drug Northera, the investor told a North Carolina federal court Friday.
August 26, 2015
A federal judge declined Wednesday to dismiss a securities class action against Chelsea Therapeutics International Ltd., but gave the parties a pointed recommendation to settle in light of the trouble similar suits have seen.